Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Zollinger-Ellison Syndrome
This study has been completed.
Study NCT00001241   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 5, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Zollinger Ellison Syndrome
Additional conditions recognized in this trial
Gastrinoma
Syndrome
Zollinger-Ellison Syndrome
More general conditions related to this trial
Adenocarcinoma
Carcinoma
Carcinoma, Islet Cell
Digestive System Diseases
Digestive System Neoplasms
Disease
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Pancreatic Diseases
Pancreatic Neoplasms
Paraneoplastic Endocrine Syndromes
Paraneoplastic Syndromes
Pathologic Processes
Peptic Ulcer
Stomach Diseases
Additional drug interventions recognized in this trial
Histamine H2 Antagonists
More general drug interventions related to this trial
Histamine Agents
Histamine Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services